Last chance saloon really - take anything you can. No real way out of this now |
I bought a few more. A lot of large holdings were built. |
This day was foretold more than a decade ago by me. |
Last day of trading and not much possibility of trading off market.
Cash burn and falling revenue were killers as was the failure to launch the non invasive monitor.
The only significant trade of the day was 271m (£81k) at 0.03p circa 14% of the company. I've no idea who the two parties were. Companies house might reveal at some point.
Good luck anyone still holding although I think they are worthless confetti and may prove impossible to trade anyway.
Dave |
Best to sell today or wait and sell during the next 12months? |
Best to sell today or wait and sell during the next 12months? |
The day of reckoning approaches.
Does anyone have experience of dealing on a "matched bargain" basis ? |
Obviously doomed fro failAll over bar shouting Sadly predictable |
Delisting seems sensible to me. It's better than insolvency. |
If I understand today's announcement properly, the Board intends to operate in the best interests of the chairman. And that's it.Maybe he is not as wholly useless as I have long thought, just not at all useful to those of us who, together, have piled in tens of millions of pounds over the 36 years of his reign.Where is any pledge to not shaft further the ordinary shareholders?Is there still time to get Keen blackballed by the market regulators? |
20 January 2025
Deltex Medical Group plc
("Deltex Medical" or the "Company")
Holding in Company
Deltex Medical Group plc (AIM: DEMG) was informed that, as a result of a purchase on 16 January 2025 of 70,325,000 ordinary shares of 0.01 pence each in the Company ("Ordinary Shares"), Michael Stubbs' holding of Ordinary Shares increased to 182,563,383 Ordinary Shares, representing approximately 9.63 per cent of the Company's issued share capital. The Company has also been informed that on 17 January 2025 Michael Stubbs bought 23,600,000 Ordinary Shares and he now holds 206,163,383 Ordinary Shares, representing approximately 10.87% of the Company's issued share capital. |
Pretty much all over - so many years of pointing this out and yet people refused to see the patently obvious. Sad day after years of deluded management and even more deluded shareholders |
The triumph of hope over experience .. 🎶 |
Visionary. |
So what do we think of this thread's headline? |
BTW, SNG have raised and are delisting as not enough cash raised in open offer, so add that to the list. |
 "waterloo01 - 20 Sep 2022 - 13:25:03 - 11729 of 11941 Deltex Medical - a British success story! - DEMG
Not been in this for some years. Reminds me of Sphere. Similar traction issues, mainly due to ....."
Hey....you....
Traction issues?
Don't you worry sunshine, plenty of Va Va Voom here!
Only messing :-)
Poor humour aside, once more the risks of holding the tiddlers are plain to see. DEMG joins JWNG, DGI, QUIZ, NMT, TRYB within the past month. Posted on a whole host of others before that. Even MRIT leaving too - that isn't in Penny Punt Land.
The big cleanse can't be stopped.
How many speculative shares have we seen over the years....promises of this hole in the ground full of...something....or some magic new drug or technological process....graphene this and that....
And they pretty much all end up in Penny Punt Land, and now it is a continuation of a barrage of de-listing's. I don't know what the number is, but the percentage that actually transform themselves must be tiny. Needle in the haystack jobbler on AIM.
But the tiddler market isn't completely closed as SNG have somehow managed to raise £18m! STX managed a decent raise in December too. So even after all the destruction out there, plenty still willing to have a punt.
Hopeful a few tiddlers do surprise with game changing news, but it is a complete and utter....
(Insert expletive here)...show
All imo
DYOR
EDIT 12:34...My bad...missed that SNG are de-listing too. Just read the headline
SNG ARE DE-LISTING TOO! Ha
What a mess. |
I wonder if any small businesses have managed to sell increasing volume of clinical products into the NHS - ever ?
NICE once mentioned “adoption at pace and scale” in reference to DEMG monitor.
That just doesn’t happen in the NHS.
Anything clinical is subject to clinicians whims. There is no overriding management power to implement as there would be in a business. However good anything is.
Its like leaving a group of R&D experts to manage themselves. |
Yes but the AIM market is useless and impossible to raise money except at wipe out dilution. |
Strange delist decision...the business is growing and it's on the turnaround path?RNS extract: The Group made good progress during FY24 as can be seen from, among other things, the year-on-year increase in revenues. The Group's unaudited revenues for FY24 were £2.1 million (2023: £1.8 million), representing an increase of approximately 17%. The Group's cash at hand at 31 December 2024 was £0.24 million (2023: £0.7 million). The new TrueVue monitor was promoted aggressively - both in the UK and internationally - and revenues from this new product are beginning to grow. |
I recall visiting DMG at their HQ for an Open Day about 20 years ago when the share price was about 20p.
Unfortunately it never delivered commercial traction or shareholder value over twenty long years.
Best wishes to all long suffering shareholders. |
So the CEO is going but the Chair, who has been a disaster over 35 years, is staying? To look after our investments with no accountability at all? |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
